The importance of clinical trials for the paediatric rheumatic diseases: Organisation, methodological and ethical problems

Research output: Contribution to journalArticle

Abstract

The paediatric rheumatic diseases are rare condition associated with important sequelae on the quality of life of these children. The research aimed at studying new therapeutic approaches is difficult because of organisation, methodological and ethical problems. To face these problems in May 1996 it was founded an international research network called 'Paediatric Rheumatology International Trials Organisation - PRINTO' with the goal to promote, facilitate and conduct high quality research in the paediatric rheumatic diseases. PRINTO is composed of 4 main vertical structures: the Advisory Council, the international co-ordinating centre located in Pavia, Italy, one national co-ordinator in each country, and 140 centres (hospitals and/or Universities) in 32 countries worldwide. PRINTO is now conducting the following studies all financed by the European Community: 1. Methotrexate in medium versus higher doses in juvenile chronic arthritis (JCA): a total of 340 patients have been enrolled in the screening phase with 42 patients randomised to higher dose of MTX. 2. Quality of life project in the JCA with the cross-cultural adaptation and validation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) with more than 4000 patients collected from 32 countries. 3. Core-set of outcome measures and definition of improvement for juvenile systemics lupus erythematosus and juvenile dermatomyositis. This international network represents a powerful tool to investigate future treatment in the paediatric rheumatic diseases.

Original languageEnglish
Pages (from-to)165-170
Number of pages6
JournalGaslini
Volume32
Issue number2
Publication statusPublished - 2000

Fingerprint

Rheumatic Diseases
Clinical Trials
Organizations
Pediatrics
Juvenile Arthritis
Research
Quality of Life
Rheumatology
European Union
Methotrexate
Systemic Lupus Erythematosus
Italy
Outcome Assessment (Health Care)
Health
Therapeutics
Surveys and Questionnaires

Keywords

  • Controlled clinical trials
  • Paediatric rheumatic diseases
  • Quality of life

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{65c7324da7dc43eb94a2c2d6c8543a5a,
title = "The importance of clinical trials for the paediatric rheumatic diseases: Organisation, methodological and ethical problems",
abstract = "The paediatric rheumatic diseases are rare condition associated with important sequelae on the quality of life of these children. The research aimed at studying new therapeutic approaches is difficult because of organisation, methodological and ethical problems. To face these problems in May 1996 it was founded an international research network called 'Paediatric Rheumatology International Trials Organisation - PRINTO' with the goal to promote, facilitate and conduct high quality research in the paediatric rheumatic diseases. PRINTO is composed of 4 main vertical structures: the Advisory Council, the international co-ordinating centre located in Pavia, Italy, one national co-ordinator in each country, and 140 centres (hospitals and/or Universities) in 32 countries worldwide. PRINTO is now conducting the following studies all financed by the European Community: 1. Methotrexate in medium versus higher doses in juvenile chronic arthritis (JCA): a total of 340 patients have been enrolled in the screening phase with 42 patients randomised to higher dose of MTX. 2. Quality of life project in the JCA with the cross-cultural adaptation and validation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) with more than 4000 patients collected from 32 countries. 3. Core-set of outcome measures and definition of improvement for juvenile systemics lupus erythematosus and juvenile dermatomyositis. This international network represents a powerful tool to investigate future treatment in the paediatric rheumatic diseases.",
keywords = "Controlled clinical trials, Paediatric rheumatic diseases, Quality of life",
author = "N. Ruperto and A. Martini",
year = "2000",
language = "English",
volume = "32",
pages = "165--170",
journal = "Gaslini",
issn = "0390-5845",
publisher = "Masson SpA",
number = "2",

}

TY - JOUR

T1 - The importance of clinical trials for the paediatric rheumatic diseases

T2 - Organisation, methodological and ethical problems

AU - Ruperto, N.

AU - Martini, A.

PY - 2000

Y1 - 2000

N2 - The paediatric rheumatic diseases are rare condition associated with important sequelae on the quality of life of these children. The research aimed at studying new therapeutic approaches is difficult because of organisation, methodological and ethical problems. To face these problems in May 1996 it was founded an international research network called 'Paediatric Rheumatology International Trials Organisation - PRINTO' with the goal to promote, facilitate and conduct high quality research in the paediatric rheumatic diseases. PRINTO is composed of 4 main vertical structures: the Advisory Council, the international co-ordinating centre located in Pavia, Italy, one national co-ordinator in each country, and 140 centres (hospitals and/or Universities) in 32 countries worldwide. PRINTO is now conducting the following studies all financed by the European Community: 1. Methotrexate in medium versus higher doses in juvenile chronic arthritis (JCA): a total of 340 patients have been enrolled in the screening phase with 42 patients randomised to higher dose of MTX. 2. Quality of life project in the JCA with the cross-cultural adaptation and validation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) with more than 4000 patients collected from 32 countries. 3. Core-set of outcome measures and definition of improvement for juvenile systemics lupus erythematosus and juvenile dermatomyositis. This international network represents a powerful tool to investigate future treatment in the paediatric rheumatic diseases.

AB - The paediatric rheumatic diseases are rare condition associated with important sequelae on the quality of life of these children. The research aimed at studying new therapeutic approaches is difficult because of organisation, methodological and ethical problems. To face these problems in May 1996 it was founded an international research network called 'Paediatric Rheumatology International Trials Organisation - PRINTO' with the goal to promote, facilitate and conduct high quality research in the paediatric rheumatic diseases. PRINTO is composed of 4 main vertical structures: the Advisory Council, the international co-ordinating centre located in Pavia, Italy, one national co-ordinator in each country, and 140 centres (hospitals and/or Universities) in 32 countries worldwide. PRINTO is now conducting the following studies all financed by the European Community: 1. Methotrexate in medium versus higher doses in juvenile chronic arthritis (JCA): a total of 340 patients have been enrolled in the screening phase with 42 patients randomised to higher dose of MTX. 2. Quality of life project in the JCA with the cross-cultural adaptation and validation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) with more than 4000 patients collected from 32 countries. 3. Core-set of outcome measures and definition of improvement for juvenile systemics lupus erythematosus and juvenile dermatomyositis. This international network represents a powerful tool to investigate future treatment in the paediatric rheumatic diseases.

KW - Controlled clinical trials

KW - Paediatric rheumatic diseases

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=0033791078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033791078&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033791078

VL - 32

SP - 165

EP - 170

JO - Gaslini

JF - Gaslini

SN - 0390-5845

IS - 2

ER -